29 October 2018 07:37 CET

EQT VIII, through Karo Intressenter AB, announces a public cash offer to the shareholders in Karo Pharma Aktiebolag

#EQT VIII #Karo Pharma

For more information, click here.

Latest news

25 July 2024
EQT to sell its stake in fiber-to-the-home network Fiberklaar
18 July 2024
EQT AB (publ) Half-year Report 2024
16 July 2024
EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round
10 July 2024
EQT AB assigned ‘A-’ (Stable) credit rating by S&P
04 July 2024
EQT and Kühne Holding invest in Flix, the global travel company